WU
16
2
AN
49
2
SWK
80
2
PNR
72
-2
PSX
42
3
DLTR
31
3
TXT
58
-2
SLG
66
4
SWN
70
3
MMC
60
-2
HPE
53
2
HSY
38
-2
PCG
74
-6
SYY
50
-8
ETR
68
-3
XOM
48
3
BAX
35
-3
NRG
57
2
AIZ
71
-2
NFLX
55
-3
WU
16
2
AN
49
2
SWK
80
2
PNR
72
-2
PSX
42
3
DLTR
31
3
TXT
58
-2
SLG
66
4
SWN
70
3
MMC
60
-2
HPE
53
2
HSY
38
-2
PCG
74
-6
SYY
50
-8
ETR
68
-3
XOM
48
3
BAX
35
-3
NRG
57
2
AIZ
71
-2
NFLX
55
-3
Financhill
Back

Oncternal Therapeutics Vs. iBio Industry Stock Comparison

Sell
3

ONCT
Oncternal Therapeutics

Last Price:
1.71
Seasonality Move:
5.35%
Sell
19

IBIO
iBio

Last Price:
1.89
Seasonality Move:
-34.73%
Sell
3
Oncternal Therapeutics (ONCT) is a Sell

Is Oncternal Therapeutics a Buy, Sell or Hold?

  • The current Oncternal Therapeutics [ONCT] share price is $1.69. The Score for ONCT is 3, which is 94% below its historic median score of 50, and infers higher risk than normal.
  • ONCT is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
19
iBio (IBIO) is a Sell

Is iBio a Buy, Sell or Hold?

  • The current iBio [IBIO] share price is $1.79. The Score for IBIO is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
  • IBIO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

ONCT Stock Price Chart

What is Oncternal Therapeutics's stock price today?

  • The Oncternal Therapeutics share price today is $1.69
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ONCT is experiencing slight buying pressure.

IBIO Stock Price Chart

What is iBio's stock price today?

  • The iBio share price today is $1.79
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IBIO is experiencing selling pressure, which indicates risk of future bearish movement.

ONCT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.95 Sell
Relative Strength Index (14 RSI): 21.44 Sell
Chaikin Money Flow: 52731 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.59 - 4.81) Sell
Bollinger Bands (100): (4.62 - 8.82) Sell

IBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 42.6 Sell
Chaikin Money Flow: -39847 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.82 - 2) Sell
Bollinger Bands (100): (1.82 - 2.28) Sell

ONCT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.52 Sell
20-day SMA: 3.61 Sell
50-day SMA: 5.08 Sell
200-day SMA: 7.77 Sell
8-day EMA: 2.3 Sell
20-day EMA: 3.3 Sell
50-day EMA: 4.73 Sell
200-day EMA: 7.26 Sell

IBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.88 Sell
20-day SMA: 1.9 Sell
50-day SMA: 1.98 Sell
200-day SMA: 1.76 Buy
8-day EMA: 1.87 Sell
20-day EMA: 1.89 Sell
50-day EMA: 1.95 Sell
200-day EMA: 4.7 Sell

Oncternal Therapeutics Earnings Growth & ONCT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $1.11 per share, an increase this year of $2.00 per share, and an increase next year of $2.22 per share.

iBio Earnings Growth & IBIO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $6.73 per share, an increase next quarter of $0.03 per share, an increase this year of $103.99 per share, and an increase next year of $5.64 per share.

Oncternal Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

iBio Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):